X-15599938-A-G

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001371415.1(ACE2):​c.186+788T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.202 in 110,167 control chromosomes in the GnomAD database, including 1,942 homozygotes. There are 6,715 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.20 ( 1942 hom., 6715 hem., cov: 22)

Consequence

ACE2
NM_001371415.1 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.155

Publications

137 publications found
Variant links:
Genes affected
ACE2 (HGNC:13557): (angiotensin converting enzyme 2) The protein encoded by this gene belongs to the angiotensin-converting enzyme family of dipeptidyl carboxydipeptidases and has considerable homology to human angiotensin 1 converting enzyme. This secreted protein catalyzes the cleavage of angiotensin I into angiotensin 1-9, and angiotensin II into the vasodilator angiotensin 1-7. ACE2 is known to be expressed in various human organs, and its organ- and cell-specific expression suggests that it may play a role in the regulation of cardiovascular and renal function, as well as fertility. In addition, the encoded protein is a functional receptor for the spike glycoprotein of the human coronavirus HCoV-NL63 and the human severe acute respiratory syndrome coronaviruses, SARS-CoV and SARS-CoV-2, the latter is the causative agent of coronavirus disease-2019 (COVID-19). Multiple splice variants have been found for this gene and the dACE2 (or MIRb-ACE2) splice variant has been found to be interferon inducible. [provided by RefSeq, Nov 2020]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.494 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001371415.1. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ACE2
NM_001371415.1
MANE Select
c.186+788T>C
intron
N/ANP_001358344.1Q9BYF1-1
ACE2
NM_021804.3
c.186+788T>C
intron
N/ANP_068576.1Q9BYF1-1
ACE2
NM_001386259.1
c.186+788T>C
intron
N/ANP_001373188.1A0A7I2V4H0

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ACE2
ENST00000252519.8
TSL:1 MANE Select
c.186+788T>C
intron
N/AENSP00000252519.3Q9BYF1-1
ACE2
ENST00000427411.2
TSL:1
c.186+788T>C
intron
N/AENSP00000389326.1Q9BYF1-1
ENSG00000285602
ENST00000649243.1
n.*264+788T>C
intron
N/AENSP00000497489.1A0A3B3IT09

Frequencies

GnomAD3 genomes
AF:
0.202
AC:
22268
AN:
110112
Hom.:
1942
Cov.:
22
show subpopulations
Gnomad AFR
AF:
0.116
Gnomad AMI
AF:
0.274
Gnomad AMR
AF:
0.344
Gnomad ASJ
AF:
0.269
Gnomad EAS
AF:
0.514
Gnomad SAS
AF:
0.439
Gnomad FIN
AF:
0.184
Gnomad MID
AF:
0.199
Gnomad NFE
AF:
0.190
Gnomad OTH
AF:
0.215
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.202
AC:
22278
AN:
110167
Hom.:
1942
Cov.:
22
AF XY:
0.207
AC XY:
6715
AN XY:
32505
show subpopulations
African (AFR)
AF:
0.116
AC:
3517
AN:
30348
American (AMR)
AF:
0.344
AC:
3548
AN:
10300
Ashkenazi Jewish (ASJ)
AF:
0.269
AC:
708
AN:
2628
East Asian (EAS)
AF:
0.514
AC:
1770
AN:
3446
South Asian (SAS)
AF:
0.439
AC:
1118
AN:
2547
European-Finnish (FIN)
AF:
0.184
AC:
1071
AN:
5810
Middle Eastern (MID)
AF:
0.196
AC:
41
AN:
209
European-Non Finnish (NFE)
AF:
0.190
AC:
9993
AN:
52700
Other (OTH)
AF:
0.217
AC:
327
AN:
1505
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
597
1194
1791
2388
2985
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
220
440
660
880
1100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.195
Hom.:
3168
Bravo
AF:
0.215

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.86
CADD
Benign
1.2
DANN
Benign
0.55
PhyloP100
-0.15
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2106809; hg19: chrX-15618061; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.